Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer.

Pharmacogenomics - 1 Jul 2021

Li Shengnan, Zhang Gengpu, Li Xin, Li Xiaojie, Chen XiaoBing, Xu Yu, Ren He

Abstract excerpt

Aim: The prognosis of resectable pancreatic cancer patients with the same stage of disease is highly variable. The purpose of this study is to establish a scoring system for preoperative screening of resectable patients. Materials & methods: The clinical information and laboratory tests of 105 resectable patients with pancreatic cancer were enrolled and analyzed. Results: The consistency of clinical stage and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Mutation

Share to Pancreatic Neoplasms

Share to Preoperative Care

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 34120460
DOI: 10.2217/pgs-2020-0183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer.PMID 34120460Read ↗

Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients.Semantic proximity Read ↗

Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasisSemantic proximity Read ↗

[Progress of circulating tumor DNA in diagnosis and prognosis of pancreatic cancer].Semantic proximity Read ↗

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer.Semantic proximity Read ↗

Development of a prediction system for KRAS mutation detection via circulating tumour DNA analysis among patients with unresectable pancreatic cancerSemantic proximity Read ↗

Predicting disease recurrence in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer PatientsSemantic proximity Read ↗

Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection.Semantic proximity Read ↗

Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer.Semantic proximity Read ↗

Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis.Semantic proximity Read ↗

Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.